Write in a clean editor, then format for Journal of Current Oncology in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Current Oncology is a peer-reviewed journal published by SAGE, covering Advanced Radiotherapy Techniques, Head and Neck Cancer Studies, Cancer Genomics and Diagnostics.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Journal of Current Oncology, 12(3), pp. 45–58.
Formats any DOI in Journal of Current Oncology style. No sign-up. |
| Publishes research in | Advanced Radiotherapy Techniques Head and Neck Cancer Studies Cancer Genomics and Diagnostics Glioma Diagnosis and Treatment Genetic factors in colorectal cancer |
| ISSN | 2589-8892 |
| Citation impact (2-yr) | 0.06 |
| h-index | 4 |
| i10-index | 2 |
| Total citations | 142 |
| Top institutions publishing here | Rajiv Gandhi Cancer Institute and Research Centre |
| Journal website | journals.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
In the last few decades, there have been major improvements in diagnosis, staging, and management of cancer which has translated into better disease outcomes and longer survival rates and with better quality of life. This improvement in the quality of life is by better normal tissue sparing caused by the increasing use of newer techniques…
Survival of patients with multiple myeloma has increased significantly during the past two decades. This has been attributed to a better understanding of biology, the introduction of novel agents (immunomodulators, proteasome inhibitors), autologous stem cell transplantation, and maintenance therapy. Supportive care is an important component of overall care for these patients. Most patients have a…
Aim: To compare the analgesic efficacy of epidural ropivacaine–fentanyl with bupivacaine–fentanyl combination administered by patient-controlled epidural analgesia (PCEA) technique for postoperative pain relief after major abdominal oncosurgery. Materials and Methods: A prospective, randomized, interventional, parallel group, active control study was conducted on 60 patients with American Society of Anesthesiologists physical status I–III. Random allocation was…
In hormone-receptor-positive breast cancer, the main treatment is tamoxifen. Tamoxifen is a weak antiestrogen that requires prior activation to its most active metabolite, endoxifen, which has superior antiestrogenic activity. In the search for predictive biomarkers to optimize treatment and reduce tamoxifen resistance, studies have concluded that endoxifen concentrations are associated with CYP2D6 activity and that…
The treatment options for recurrent tumors are limited. Re irradiation is being increasingly considered as an option, in view of the advances in treatment techniques, particularly the ability to document doses, overlay plans, intensity modulation, and image guidance. preclinical and clinical studies has been to estimate the total cumulative doses (EQD2) also termed as normalized…
